Moore Capital Management LP Purchases 130,296 Shares of Ralliant Corporation $RAL

Moore Capital Management LP boosted its position in shares of Ralliant Corporation (NYSE:RAL) by 106.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 252,690 shares of the company’s stock after acquiring an additional 130,296 shares during the quarter. Moore Capital Management LP owned 0.22% of Ralliant worth $11,050,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after acquiring an additional 1,415,327 shares during the period. Dodge & Cox acquired a new position in shares of Ralliant during the 2nd quarter worth about $523,571,000. Viking Global Investors LP bought a new stake in shares of Ralliant in the 2nd quarter valued at about $257,200,000. State Street Corp bought a new stake in shares of Ralliant in the 2nd quarter valued at about $213,096,000. Finally, Flossbach Von Storch SE lifted its stake in Ralliant by 1.7% in the 3rd quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock valued at $181,605,000 after purchasing an additional 67,963 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on RAL shares. Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Royal Bank Of Canada dropped their price objective on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research note on Friday, February 6th. Zacks Research cut Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Morgan Stanley reiterated an “overweight” rating and set a $45.00 target price on shares of Ralliant in a research note on Friday, February 6th. Finally, Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a report on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $50.50.

Ralliant Price Performance

NYSE:RAL opened at $42.76 on Tuesday. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. The firm’s 50-day simple moving average is $48.06 and its 200 day simple moving average is $46.76. The firm has a market cap of $4.78 billion and a price-to-earnings ratio of 21.82.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. Ralliant’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Ralliant’s dividend payout ratio is currently 10.20%.

Insider Activity

In related news, Director Anelise Angelino Sacks bought 2,000 shares of the business’s stock in a transaction dated Monday, February 9th. The stock was purchased at an average cost of $41.25 per share, for a total transaction of $82,500.00. Following the transaction, the director owned 5,403 shares in the company, valued at $222,873.75. The trade was a 58.77% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kate Mitchell bought 2,350 shares of Ralliant stock in a transaction dated Tuesday, February 10th. The shares were bought at an average cost of $42.48 per share, for a total transaction of $99,828.00. Following the completion of the acquisition, the director owned 8,411 shares in the company, valued at $357,299.28. This represents a 38.77% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have purchased 8,145 shares of company stock worth $332,233.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.